Media Coverage Archives - Page 26 of 30 - Lupin

BSE 2296.10 NSE 2296.10

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2296.10 NSE 2296.10

This #BusinessStandard feature talks about how several prescription brands are making the shift towards Over the counter (OTC) products. Anil Kaushal, Head of OTC Business at Lupin shares his thoughts

August 30, 2020

Lupin’s Albuterol launch will boost US revenue stocks is priced to perfection

August 27, 2020

New inhalation product helps Lupin’s revenue visibility

August 27, 2020

Vinita Gupta, CEO Lupin, on CNBC TV18 BAZAAR Open Exchange 26 Aug 2020 Nod For Albuterol

Vinita Gupta, CEO Lupin, on CNBC TV18 BAZAAR Open Exchange 26 Aug 2020 Nod For Albuterol

August 26, 2020

Ramesh Swaminathan, CFO Lupin, with ET Now First Trades 26 Aug 2020 USFDA Nod For Alb

Ramesh Swaminathan, CFO Lupin, with ET Now First Trades 26 Aug 2020 USFDA Nod For Alb

August 26, 2020

Lupin first company to shift manufacturing of some drugs from India to US after Trump’s ‘Buy American’ order – Vinita Gupta

August 11, 2020

July Brings Cheer to Job Seekers – Yashwant Mahadik

Combating COVID-19 through caring – Alok Sonig

THE WEEK Magazine | Analytical story on India-China business Debabrata Chakravorty’s quote

Ramesh Swaminathan on ET Now

Ramesh Swaminathan on ET Now

1 2 … 25 26 27 … 29 30

Search

Hit enter to search or ESC to close